Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate drug–drug interaction and food effect of sudapyridine (WX-081) when co-administered with itraconazole and rifampin in healthy Chinese …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itraconazole (Itraconazole)
  • RIFAMPIN (RIFAMPIN)
  • Sudapyridine (WX-081) (sudapyridine)

Snippet

Sponsor: Shanghai Jiatan Pharmatech Co., Ltd | Conditions: Rifampicin-Resistant Pulmonary Tuberculosis Patients | Phase 1 | Status: NOT_YET_RECRUITING